Page 2 - Morphosys Daily News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Morphosys daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Morphosys Daily Today - Breaking & Trending Today

MorphoSys (NASDAQ:MOR) Sets New 1-Year High at $18.38

MorphoSys (NASDAQ:MOR) Sets New 1-Year High at $18.38
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

United States , Morphosys Company Profile , Morgan Stanley , Quadrant Capital Group , Wells Fargo Company , Exchange Traded Concepts , Virtu Financial , Get Free Report , Capital Group , Traded Concepts , Financial Markets , Morphosys Daily ,

MorphoSys (NASDAQ:MOR) Shares Gap Down to $18.04

MorphoSys (NASDAQ:MOR) Shares Gap Down to $18.04
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Hennion Walsh Asset Management Inc , Henry James International Management Inc , Quadrant Capital Group , Exchange Traded Concepts , Wells Fargo Company , Virtu Financial , Morgan Stanley , Get Free Report , Sys Stock Down , Capital Group , Traded Concepts , James International Management , Walsh Asset Management , Morphosys Daily ,

MorphoSys AG (NASDAQ:MOR) Receives $11.78 Consensus Target Price from Brokerages

MorphoSys AG (NASDAQ:MOR) Receives $11.78 Consensus Target Price from Brokerages
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Leerink Partnrs , Virtu Financial , Cubist Systematic Strategies , Jpmorgan Chase Co , Wells Fargo Company , Pricet Rowe Associates Inc , Morgan Stanley , Goldman Sachs Group Inc , Morphosys Company Profile , Get Free Report , Sachs Group , Systematic Strategies , Sys Stock Down , Get Free , Morphosys Daily ,

Financial Survey: MorphoSys (OTCMKTS:MPSYF) vs. BioRestorative Therapies (OTCMKTS:BRTX)

MorphoSys (OTCMKTS:MPSYF – Get Free Report) and BioRestorative Therapies (OTCMKTS:BRTX – Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, profitability, dividends, risk and analyst recommendations. Insider and Institutional Ownership 69.4% of BioRestorative Therapies shares […] ....

New York , United States , Biorestorative Therapie , Mereo Biopharma , University Of Pennsylvania , Pfizer Inc , Biorestorative Therapies Inc , Rohto Pharmaceutical Co Ltd , Human Immunology Biosciences Inc , Metabolic Program Thermostem , Xencor Inc , Incyte Corporation , Stem Cell Assurance Inc , Get Free Report , Biorestorative Therapies , Restorative Therapies , Given Biorestorative Therapie , I Mab Biopharma , Anthos Therapeutics , Human Immunology Biosciences , Metabolic Program , Stem Cell Assurance , Morphosys Daily , Otcmkts Mpsyf , Stock Comparison , Stock Analysis ,

Wells Fargo & Company Reaffirms Overweight Rating for MorphoSys (NASDAQ:MOR)

Wells Fargo & Company reaffirmed their overweight rating on shares of MorphoSys (NASDAQ:MOR – Free Report) in a report issued on Monday, Benzinga reports. They currently have a $17.00 price objective on the stock. Several other analysts also recently commented on MOR. Leerink Partnrs restated a market perform rating on shares of MorphoSys in a […] ....

United States , Leerink Partnrs , Wells Fargo Company , Sigma Securities , Qube Research Technologies Ltd , Jpmorgan Chase Co , Morphosys Company Profile , Virtu Financial , Morgan Stanley , Goldman Sachs Group , Wells Fargo , Free Report , Moderate Buy , Get Free Report , Technologies Ltd , Two Sigma Securities , Morphosys Daily , Nasdaq Mor , Reiterated Rating ,